For successful general anesthesia of an animal, the smooth induction of anesthesia is pivotal. One acceptable method to induce anesthesia in cooperative or high-risk animals is to progressively increase the concentration of volatile anesthetics inhaled through a face mask \[[@r7], [@r14], [@r16]\]. Using this method, the concentration of the anesthetic is gradually increased starting from 0% of the agent, i.e., 100% carrier gas. If the animal can accept the physical restraint and face mask, this method offers the advantage of being able to accurately control the anesthetic depth during the induction, as well as offers the safety of being able to immediately discontinue the administration of the anesthetics if problems arise. Another acceptable method in cooperative animals is total intravenous anesthesia \[[@r19]\]. Both of these methods require the cooperation of animals and thus cannot be applied to healthy non-cooperative animals.

The common marmoset (*Callithrix jacchus*) is a non-human primate species with distinctive features, such as small body size (weighing 300 to 450 g) and high fecundity. Marmosets have recently been increasingly used in biomedical research \[[@r2], [@r12], [@r20]\]. However, marmosets are extremely sensitive to physical restraint; it has been reported that their resting heart rate measured in their home cage was approximately 230 beats min^−1^, but increased to approximately 348 (arterial catheter method) or 312 (tail-cuff method) beats min^−1^ when they were kept in a restraint tube, even when they were accustomed to the apparatus and the procedure \[[@r18]\]. Thus, in common marmosets, minimizing their anxiety and stress is essential for the smooth induction of anesthesia. A practical solution is the combined administration of injectable agents followed by inhalational agents; the former should shorten the time to reach and pass Stage 2 of anesthesia, which is the stage of excitement or involuntary movement \[[@r9]\], and the latter should enable the control of anesthetic depth during the induction and maintenance of anesthesia.

As an injectable anesthetic agent, ketamine has some advantages, such as rapid action, a wide safety margin, and little cardiovascular and respiratory depression \[[@r8]\], and thus is by far the most widely used anesthetic in non-human primate surgical procedures \[[@r5]\]. However, ketamine has limited effects of skeletal muscle relaxation, and its effects differ greatly among individuals \[[@r6]\]. Furthermore, ketamine is more suitable for chemical immobilization than for anesthesia, as increasing its dose only extends the duration of action and does not lead to deeper anesthesia \[[@r6]\]. The aim of this study was to test the working hypothesis that the addition of analgesics and sedatives to ketamine and sevoflurane would improve the induction of anesthesia in marmosets.

This study is based on a retrospective analysis of the records of anesthesia induction in common marmosets, and thus, no ad hoc animal experiments were performed. All the original animal experiments were approved by the ethics committee for primate research of the National Center of Neurology and Psychiatry, Japan, and were conducted in accordance with the institutional guidelines and with the Guidelines for Proper Conduct of Animal Experiments by the Science Council of Japan. The marmosets, ranged from 1 to 10 years old, were caged indoors, with the room lights on from 0700 to 1900 hr, the temperature at 26 to 28°C, the humidity at 40 to 60% and a ventilation rate of 15 air changes per hour. The marmosets were fed 50 g a day of monkey chow (CMS-1M, Clea Japan Inc., Tokyo, Japan) with vitamin supplementation and fruit. Water was provided *ad libitum*. Marmosets were pair-housed for example in an embryo collection study or single-housed when pairing was not possible for example in an embryo transfer study.

Animals were given an intramuscular (IM) injection of either ketamine (30 mg kg^−1^; Ketalar, Daiichi-Sankyo, Tokyo, Japan) alone or a combination of midazolam (0.30 mg kg^−1^; Dormicum, Astellas Pharma Inc., Tokyo, Japan), butorphanol (0.015 mg kg^−1^; Stadol, Bristol-Myers Squibb, Tokyo, Japan) and ketamine (10 mg kg^−1^). These doses were selected by referring to the literature \[[@r15]\]. A 29-gauge needle attached to a 0.3 m*l* insulin syringe (Becton, Dickinson and Co., Franklin Lakes, NJ, U.S.A.) was used to deliver the calculated injectable anesthetic agents. As soon as the righting reflex disappeared, 5% sevoflurane (Sevofrane, Maruishi Pharmaceutical Co., Ltd., Osaka, Japan) with carrier gas, i.e., 80--100% oxygen, was administered at 500 m*l* min^−1^ through a face mask (Narcobit K-100RG, Natsume Seisakusho Co., Ltd., Tokyo, Japan) \[[@r13]\]. Fore-paw or hind-paw arterial oxygen saturation and pulse rate were monitored using a pulse-oximeter (8600FO, Nonin Medical Inc., Plymouth, MN, U.S.A.) and were recorded on a personal computer. Anesthetic depth was assessed by the pulse rate and the pinch reflex. When the pulse rate dropped below 250 beats min^−1^, the pinch reflex was examined by manual pinching of the hind limbs. The induction of anesthesia was considered to be successful when the pinch reflex disappeared within 15 min after the IM injection. In all other cases, anesthesia induction was considered to be unsuccessful.

Anesthesia induction was attempted in 372 marmosets with either ketamine-sevoflurane (Ket-Sev) or midazolam-butorphanol-ketamine-sevoflurane (MBK-Sev) regimens. The righting reflex disappeared within a few min in all animals. However, anesthesia induction was not successful in 7 out of 99 animals receiving Ket-Sev and in 2 out of 273 animals receiving MBK-Sev. The frequency of unsuccessful anesthesia induction differed between the 2 regimens (two-tailed Fisher's exact test, *P*=0.00176). Exemplified vital signs during the abdominal procedures are shown in [Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Exemplified vital signs during the abdominal procedures. Time 0 indicates the start of monitoring which was about two min after the intramuscular administration of the injectable agents. Left: anesthesia was induced with ketamine and sevoflurane. Right: anesthesia was induced with midazolam, butorphanol, ketamine and sevoflurane.. There were no cases of anesthesia-induced accidental death in both groups, indicating that both anesthesia regimens are safe for anesthesia induction in marmosets.

Ket-Sev has been used for the induction of anesthesia, with the expectation that ketamine would act towards achieving chemical immobilization and sevoflurane would act towards achieving anesthesia. Contrary to this expectation, the Ket-Sev regimen did not induce anesthesia in 7 out of 99 animals. Chemical immobilization using ketamine may be insufficient for the reduction of anxiety in marmosets. If this is the case, it would be better to avoid this regimen, even for non-invasive procedures. On the other hand, the use of midazolam in MBK-Sev regimen is suited to the concept of balanced anesthesia; it allowed reduction of anxiety and stress which then contributed to improve the anesthesia induction.

When the intended experimental procedure included surgery, e.g., neurosurgery or abdominal surgery, the anesthesia was induced as described above and was followed by additional manipulations, such as endotracheal intubation or intravenous catheterization as required, and the anesthetic status was smoothly shifted to maintenance anesthesia with sevoflurane. The induction of anesthesia, maintenance of anesthesia and recovery from anesthesia were smooth. Thus, MBK-Sev administration appears to achieve a high overall quality of anesthesia.

The safety of sedation and anesthesia varies among small animal species: the anesthetics-related mortality rate is 0.17% (163/98,036) in dogs, 0.24% (189/79,178) in cats, 1.39% (114/8,209) in rabbits and 3.80% (49/1,288) in guinea pigs \[[@r3]\]. This variability is likely to be a result of the number of animals that have been anesthetized, and hence, the amount of data available on that species, and the body size. Although there have apparently been no reports to date on the mortality of marmosets upon anesthesia, considering their risk factors, such as their high stress level and small body size, their mortality rate upon anesthesia is likely to be high among small animal species. Furthermore, a bolus injection of the anesthetic, such as that administered to the animals in this study, is a potential risk factor. Taking these factors into account, the absence of any incidences of accidental death in the 273 marmosets administered with MBK-Sev in this study indicates that this method of anesthesia induction is safe for marmosets.

Induction of anesthesia using MBK-Sev is likely to result in a wider spectrum of analgesic effects than that using Ket-Sev. The visceral analgesic effects of ketamine are controversial \[[@r1], [@r4], [@r16], [@r17]\] and unclear. On the other hand, butorphanol was shown to exert visceral analgesic effects, and thus, MBK-Sev is considered to be better than Ket-Sev for abdominal procedures. Indeed, MBK-Sev was effectively used in non-surgical embryo collection \[[@r10]\] and non-surgical embryo transfer procedures \[[@r11]\] of marmosets; in these studies, the same animals were repeatedly subjected to the manipulations, and yet, they retained good health and successfully achieved pregnancy after embryo transfer. Therefore, MBK-Sev administration enables the well-balanced anesthesia of marmosets.

Multi-modal analgesia, by combining different acting drugs, is expected to augment or complement drug action of each drug and to reduce side effects of each drug, by reduction of each dose and antagonizing actions. Indeed, another advantage of MBK-Sev over Ket-Sev regimen is the reduction of the side effects of ketamine, such as excessive salivation or vomiting.

In conclusion, anesthesia induction in common marmosets using a combination of 0.30 mg kg^−1^ of midazolam, 0.015 mg kg^−1^ of butorphanol and 10 mg kg^−1^ of ketamine, followed by inhalation of 5% sevoflurane should enable us to perform short and non-invasive procedures reliably, and should also enable us to perform long or invasive procedures, such as surgery, in combination with the proper subsequent maintenance anesthesia.
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